Abstract
Bupropion is an increasingly prescribed agent to aid in smoking cessation. However it has important drug-drug interactions related to the cytochrome P450 system. One of these is its inhibition of the metabolism of the commonly used beta-blocker, metoprolol. The authors describe a case of severe bradycardia related to the addition of bupropion to the medical regimen of a patient on metoprolol.
Similar content being viewed by others
References
Guzey C, Norstrom A, Spigset O. Change from the CYP2D6 extensive metabolizer to the poor metabolizer phenotype during treatment with bupropion. Therapeutic Drug Monitoring 2002;24:436–437.
Shad MU, Preskorn SH. A possible bupropion and imipramine interaction. J Clin Psychopharmacol 1997;118- 119.
Nemeroff CB, Delane CL, Pollock BG. Newer antidepressants and the cytochrome P450 system. Am J Psychiatry 1996;153:311–320.
Edeki TI, He H, Wood AJJ. Pharmacogenetic explanation for excessive B-blockade following timolol eye drops: Potential for oral-ophthalmic drug interaction. JAMA 1995;274:1611- 1613.
Dinai Y, Mordechar S, Haveh N, Halkin H. Bradycardia induced by interaction between quinidine and ophthalmic tim-olol. Ann Intern Med 1985;103:890–891.
Weinshilboum R. Inheritance and Drug Response. NEngl J Med 2003;348:529–537.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
McCollum, D.L., Greene, J.L. & McGuire, D.K. Severe Sinus Bradycardia after Initiation of Bupropion Therapy: A Probable Drug-Drug Interaction with Metoprolol. Cardiovasc Drugs Ther 18, 329–330 (2004). https://doi.org/10.1023/B:CARD.0000041254.15807.98
Issue Date:
DOI: https://doi.org/10.1023/B:CARD.0000041254.15807.98